Company profile: Enzyme
1.1 - Company Overview
Company description
- Provider of software that helps life sciences and biopharma companies navigate FDA approval and regulatory compliance, enabling them to reduce reliance on costly consultants and cut compliance costs by up to 50%.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Enzyme
Sedgwick
HQ: United States
Website
- Description: Provider of technology-enabled claims and productivity management solutions in North America, delivering cost-effective claims, productivity, managed care, risk consulting, and other services through the expertise of nearly 11,000 colleagues across some 200 offices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sedgwick company profile →
PQ Systems
HQ: United States
Website
- Description: Provider of software solutions and services to implement quality improvement, optimize process performance, improve product quality, and mitigate supply chain risk, including SQCpack SPC software, GAGEpack gage management for calibration and compliance, and Quality Advisor, an online reference for SPC, process capability, and measurement systems analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PQ Systems company profile →
Compliance.ai
HQ: United States
Website
- Description: Provider of regulatory change management software and a machine learning-powered compliance platform for financial services firms and compliance professionals. Offerings include automated monitoring of regulatory updates, mapping to policies and controls, an auditable change management process, Expert-in-the-Loop methodology, developer program access to regulation data, and weekly/quarterly regulatory reports.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Compliance.ai company profile →
ANX
HQ: United States
Website
- Description: Provider of managed network, transaction delivery, and product lifecycle management products and services in the United States and Canada, offering software-as-a-service applications, any-to-any translations, B2B transaction management, and transactional communications solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ANX company profile →
IPI Software
HQ: United Kingdom
Website
- Description: Provider of software solutions that solve complex business process issues, leveraging experienced manufacturing engineers and a dynamic software development team, with unique value derived from deep understanding of complex manufacturing processes and systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IPI Software company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enzyme
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Enzyme
2.2 - Growth funds investing in similar companies to Enzyme
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enzyme
4.2 - Public trading comparable groups for Enzyme
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →